Seagen Inc.
SGENDelisted Dec 14, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001060736
Seagen Inc. was delisted on Dec 14, 2023; its insiders filed their last Form 4 on Dec 18, 2023; 614 institutions reported holding it in 13F filings for Q3 2023, worth $36.3B in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Seagen Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
SGEN is no longer listed, and 13F filings after Q3 2023 list far fewer holders. See Q3 2023
- Institutional holders
- 0
- −5 vs. Q4 2023
- Shares held
- 0
- −1.71K (−100.0%) vs. Q4 2023
- Total value
- $0
- −$386.8K (−100.0%) vs. Q4 2023
- New holders
- 0
- 0 more added
- Sold out
- 5
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 5 | $386.8K |
| Q3 2023 | 614 | $36.3B |
| Q2 2023 | 592 | $32.0B |
| Q1 2023 | 574 | $33.6B |
| Q4 2022 | 534 | $21.4B |
| Q3 2022 | 536 | $22.2B |
| Q2 2022 | 546 | $29.0B |
| Q1 2022 | 501 | $24.0B |
| Q4 2021 | 521 | $25.4B |
| Q3 2021 | 476 | $27.9B |
| Q2 2021 | 471 | $25.5B |
| Q1 2021 | 493 | $22.3B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Seagen Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% | −1,422−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −152−100.0% | Sold out |
| Fairfield, Bush & Co. | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Valued Wealth Advisors LLC | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Spotlight Asset Group, Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |